CBD for Individuals at Risk for Alzheimer's Disease | MicrobiomeTrials← Back to trialsNCT05822362
CBD for Individuals at Risk for Alzheimer's Disease
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2024-01-19Est. Completion: 2028-04
Enrollment target: 236 participants Locations- University of Colorado - Anschutz Medical Campus, Aurora, Colorado, United States
Other microbiome trials you might be interested in
Mild Cognitive ImpairmentAlzheimer DiseaseDementia
The Alzheimer's Disease Neuroimaging Initiative 4 (ADNI4) is a non-randomized, longitudinal, natural history study desig…
Birmingham, United StatesCompleted Jul 31, 2027
ICU Acquired WeaknessSepsisShockCritical IllnessMicrocirculation
This study aims to investigate how sepsis and critical illness can impair the cardiovascular system and microcirculation…
Winnipeg, CanadaEst. completion Dec 2029